Clinical Trials Logo

Filter by:
NCT ID: NCT00445822 Recruiting - Clinical trials for Myeloid Leukemia, Chronic

Registration of Children With CML and Treatment With Imatinib

CML-paed II
Start date: March 2007
Phase: N/A
Study type: Observational

Newly diagnosed pediatric patients (age < 19 years) with bcr-abl-positive CML will be treated with imatinib. Serial monitoring of treatment response is performed in one month intervals during the first three months of treatment and in three months intervals thereafter. Patients with non-response, poor response (either molecular, cytogenetic, or hematologic non-/poor response) or progress of the disease while under imatinib treatment will stop imatinib and undergo stem cell transplantation. All responders to imatinib treatment with an HLA matched donor will undergo stem cell transplantation not later than 2 years after diagnosis.

NCT ID: NCT00439933 Recruiting - Obesity Clinical Trials

Weight Loss in Obese Children and Adolescents and Its Effect on Improvement of Destructive Changes in Blood Vessels

Start date: April 2007
Phase: N/A
Study type: Interventional

Obesity in children and adolescents is associated with morphologic and functional changes of the vascular wall, suggesting a potential role of juvenile obesity for the development of atherosclerosis later in life. However, no evidence from intervention studies has been provided so far that weight loss in obese children can improve vascular function. Therefore we designed this study including a cohort of obese children before and after a structured weight reduction program in order to answer the question, whether such an intervention can improve vascular function and reverse destructive vascular changes.

NCT ID: NCT00436098 Recruiting - Clinical trials for Heart Defects, Congenital

Pediatric Exercise With Congenital Heart Defects (Kinderturnen Mit Angeborenem Herzfehler)

Start date: February 2007
Phase: N/A
Study type: Interventional

Children with congenital heart defects have shown to develop motor coordinative deficiencies. In this study we want to show that a motor pedagogic physical training can improve the coordinative capabilities of children aged 4-6 years.

NCT ID: NCT00431509 Recruiting - Osteoarthritis Clinical Trials

Trial Comparing Navigated and Conventional Implantation Techniques in Knee Replacement Surgery

Start date: January 2007
Phase: Phase 4
Study type: Interventional

This study is undertaken to investigate the effect of navigated knee implantation surgery on physical function, joint stiffness, pain, quality of life and coordinative abilities. One group of patients will receive navigated knee implantation surgery, the other traditional knee implantation surgery, without use of the navigation system. The study is designed as a randomized trial. That means that all patients who have given their consent to participate in this study will be allocated to either navigated or conventional surgery by chance. A total of 477 patients will be included in this study and will be followed up for 12 month. In this period all patients will be asked to fill in functional and quality of life questionnaires at baseline, 6 weeks and 3, 6 and 12 month follow-up. Coordinative abilities will be evaluated once in the time-frame 3 to 6 months postoperatively.

NCT ID: NCT00431145 Recruiting - Clinical trials for Coronary Artery Disease

Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)

Start date: October 2006
Phase: Phase 2
Study type: Interventional

Aim of the study is to show additional effects of the combined therapy of niacin and statins analyzing number and function of EPCs and other stem cell populations and adiponectin as well as hsCRP levels in patients with CAD.

NCT ID: NCT00426049 Recruiting - Clinical trials for Coronary Artery Disease

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The purpose of the present study is to provide the first in-human safety and efficacy evaluations of systemic oral anti-proliferative Everolimus therapy compared to placebo in patients treated by bare metal stents for significant coronary artery disease. The aim is to reduce Major Adverse Cardiac Events (MACEs) including death, coronary artery bypass grafting (CABG) to the target vessel, Q-wave and non-Q-wave myocardial infarction, and target lesion revascularization within the first 6 months after intervention. Additionally safety and tolerability of Everolimus at the selected dose in this patient population will be analyzed.

NCT ID: NCT00421486 Recruiting - HIV Infections Clinical Trials

Oral Human Papillomavirus Infection in HIV-infected Men

Start date: March 2006
Phase: N/A
Study type: Observational

Human papillomavirus (HPV)-infection belong to the most common sexually transmitted diseases worldwide. HIV-infected men having sex with men /MSM) are strongly associated with a higher prevalence of genitoanal HPV-infection, and perianal HPV-infections have been detected in up to 90% of HIV-positive men. The data concerning the incidence of oral HPV-infection in HIV-positive men, especially in the era of highly antiretroviral therapy, are conflicting. Thus, this prospective study mainly focuses on the incidence and prevalence of oral HPV-infection, spectrum of HPV-types, and oral high-risk HPV viral load in HIV-positive men.

NCT ID: NCT00415896 Recruiting - Clinical trials for Chronic Respiratory Failure

Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance

Start date: December 2006
Phase: N/A
Study type: Interventional

This study investigates how different degrees of muscular unloading during mechanical ventilation impact endurance of succeeding spontaneous breathing trials

NCT ID: NCT00414739 Recruiting - Eye Diseases Clinical Trials

Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells

Start date: n/a
Phase: Phase 1
Study type: Interventional

The study analysis the influence of benzalkonium chloride on the density of antigen presenting Langerhans cells. This is achieved in a double blind randomized study using in-vivo confocal microscopy to identify and quantify Langerhans cells of the human cornea in its central and peripheral part. This study design is based on observations with raised Langerhans cell density after the application of benzalkonium chloride containing eye drops in glaucoma patients.

NCT ID: NCT00411840 Recruiting - Clinical trials for Peripheral Arterial Disease

Novel Therapy of PAD by Combined Transplantation of BMCs

Start date: July 2004
Phase: Phase 1
Study type: Interventional

We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb. After 2 and 13 months walking distance and perfusion indices were monitored.